FDA to offer bonus payments to staffers who complete speedy drug reviews

WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of schedule, the latest in a flurry of changes to longstanding norms and procedures. FDA Commissioner Marty Makary described the effort as a p...

Redirecting to full article...